Physician

Venkat Pavan Reddy Kancharla, M.D

According to 2025 Medicare claims, Venkat Kancharla, M.D (NPI: 1205091758) practices medical oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is CANCER CARE CENTERS OF BREVARD INC (NPI: 1467551762; TIN: 593169766) and primary practice location at 32909-2200. Kancharla is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Kancharla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 752 traditional Medicare patients, billed 245,377 HCPCS/CPT codes, and received $3,831,967 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,042 prescription claims across 495 beneficiaries totaling $6,853,803 in drug costs, led by Revlimid (Lenalidomide). DME data shows 83 claims. Open Payments data shows 457 records totaling $270,052. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,537,882 to $3,831,967. Similarly, Part D prescription costs have risen steadily, from $1,328,570 to $6,853,803. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,025 to $677.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	502	145,424	$1,537,882
2016	536	175,836	$2,293,909
2017	552	192,078	$2,166,866
2018	666	238,944	$2,982,295
2019	651	224,532	$3,407,792
2020	656	265,243	$3,761,328
2021	733	263,757	$4,108,971
2022	624	257,564	$4,213,851
2023	587	222,079	$3,388,496
2024	752	245,377	$3,831,967

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	1,254	$1,328,570
2016	250	1,828	$1,783,583
2017	275	1,897	$3,060,436
2018	286	1,849	$3,632,280
2019	333	2,294	$4,299,896
2020	366	2,996	$4,929,668
2021	399	2,735	$4,719,347
2022	428	2,541	$4,429,194
2023	448	2,734	$5,043,767
2024	495	3,042	$6,853,803

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	47	$3,448
2016	N/R	43	$7,881
2017	N/R	26	$5,060
2018	N/R	42	$6,284
2019	N/R	86	$15,709
2020	N/R	119	$17,726
2021	N/R	116	$17,484
2022	N/R	92	$14,764
2023	N/R	37	$13,523
2024	N/R	83	$14,697

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	234	430	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	348	730	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	166	319	$65
36415	Insertion of needle into vein for collection of blood sample	164	426	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	177	627	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	70	1,813	$1,192,626
Lenalidomide	Lenalidomide	65	1,778	$751,305
Qinlock	Ripretinib	11	330	$458,725
Pomalyst	Pomalidomide	20	560	$445,125
Jakafi	Ruxolitinib Phosphate	25	750	$429,782

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$13,121
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$499
J8521	Capecitabine, oral, 500 mg	N	N/R	16	$487
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	287	$14,184	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	170	$255,868	Daiichi Sankyo Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Venkat Pavan Reddy Kancharla, M.D?

Tedicare shows public-source Medicare data for Venkat Pavan Reddy Kancharla, M.D (NPI 1205091758), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Venkat Pavan Reddy Kancharla, M.D have ACO affiliation data?

Venkat Pavan Reddy Kancharla, M.D is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Venkat Pavan Reddy Kancharla, M.D?

Venkat Pavan Reddy Kancharla, M.D is linked to CANCER CARE CENTERS OF BREVARD INC (billing NPI 1467551762) in the available physician profile data.

Does Venkat Pavan Reddy Kancharla, M.D have Open Payments data?

Venkat Pavan Reddy Kancharla, M.D has 457 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.